Organometallics
Article
aniline, 5 mol % of Pd(OAc)2, 5 mol % of rac-BINAP, 140 mol % of
sodium tert-butoxide, and 15 mL of dry toluene in a Schlenk flask
under nitrogen. The mixture was heated to 100 °C for 48 h and then
filtered and purified by column. The desired ligands were usually
obtained as yellow-orange oils (HL1a−c and HL1e−h) or crystalline
solids (HL1d and HL1i) in ∼66−89% yields. Characterizations of
HL1b,d,f have been reported previously.20
K): δ 10.63 (1H, s, NH), 7.79 (1H, d, ArH), 7.63 (3H, d, ArH),
7.46(1H, d, ArH), 7.29(2H, m, ArH), 7.11(1H, m, ArH), 7.03(2H, m,
ArH), 6.97(4H, m, ArH), 6.78(1H, m, ArH), 4.31 (1H, t,
NCH(R)CH2O), 4.00 (2H, m, NCH(R)CH2O), 1.65 (1H, m,
CHCH3), 0.93 (3H, d, CHCH3), 0.85 (3H, d, CHCH3). 13C NMR
(CDCl3, 298 K): δ 163.33 (CN), 157.78, 148.29, 144.95, 133.89,
131.84, 130.12, 129.69, 124.08, 122.89, 122.71, 120.92, 120.40, 118.20,
117.50, 113.75, 111.59, 73.15 (NCH(R)CH2O), 69.18 (NCH(R)
CH2O), 33.29 (CHMe2), 19.17 (CHMe2), 18.86 (CHMe2). GC/MS:
m/z 372 [M]+, 329, 299, 286 (100), 245, 209, 167. HRMS (EI+): m/z
calcd for C24H25N2O2 [M + H]+ 373.19160; found 373.18851.
Synthesis of Aluminum Complexes. In a typical procedure,
ligand HL1 (1.0 mmol) was mixed with 1.2 or 1.5 equiv of AlMe3 in
toluene. The mixture was stirred under nitrogen at room temperature
for 12 h. After removal of toluene in vacuo, the resulting yellow-orange
residue was extracted multiple times with dry hexanes and combined.
The solvent was then removed in vacuo at low temperature, affording
the product as a yellow powder. The products can be further purified
by recrystallization from a dichloromethane−hexane solution.
(4S)-4,5-Dihydro-2-(2′-anilinophenyl)-4-isopropyloxazole (HL1a).
1
Yield: 1.0 g (3.57 mmol), 86%. H NMR (CDCl3, 298 K): δ 10.55
(1H, s, NH), 7.73 (1H, d, ArH), 7.28 (4H, m, ArH), 7.20 (2H, d,
ArH), 6.97 (1H, t, ArH), 4.29 (1H, m, NCH(R)CH2O), 4.05 (1H, m,
NCH(R)CH2O), 3.96 (1H, m, NCH(R)CH2O), 1.71 (1H, m,
CHCH3), 0.97 (3H, d, CHCH3), 0.88 (3H, d, CHCH3). 13C NMR
(CDCl3, 298 K): δ 163.75 (CN), 145.73, 141.74, 132.09, 130.12,
129.51, 122.77, 121.55, 117.10, 113.28, 110.59, 73.16 (NCH(R)-
CH2O), 69.28 (NCH(R)CH2O), 33.59 (CHMe2), 19.24 (CHMe2),
19.02 (CHMe2). GC/MS: m/z 280.0 [M]+, 237.0 (100), 206.9, 193.9,
179.9, 166.9. HRMS (EI+): m/z calcd for C18H21N2O [M + H]+
281.16539; found 281.16457.
(L1a)AlMe2 (2a).28 Yield: 315 mg (0.935 mmol), 69%. [α]D = +359°
(4R)-4,5-Dihydro-2-(2′-anilinophenyl)-4-phenyloxazole (HL1c).27
Yield: 304 mg (0.968 mmol), 88%. 1H NMR (CDCl3, 298 K): δ
10.39 (1H, s, NH), 7.80 (1H, d, ArH), 7.22 (6H, m, ArH), 7.17−7.15
(3H, m, ArH), 7.08 (2H, t, ArH), 6.96 (1H, t, ArH), 6.69 (1H, t, ArH),
5.39 (1H, m, NCH(R)CH2O), 4.63 (1H, m, NCH(R)CH2O), 4.06
(1H, m, NCH(R)CH2O). 13C NMR (CDCl3, 298 K): δ 165.25,
146.25, 142.69, 141.44, 132.48, 130.40, 129.45, 128.97, 127.78, 126.73,
123.21, 122.32, 117.11, 113.36, 110.10, 73.31 (NCH(R)CH2O), 70.32
(NCH(R)CH2O). GC/MS: m/z 314 [M]+, 283, 205, 194 (100), 167,
91. HRMS (EI+): m/z calcd for C21H18N2O [M]+ 314.14191; found
314.14866.
1
(c 1.5, toluene). H NMR (CDCl3, 298 K): δ 7.67 (1H, d, J = 10,
ArH), 7.39 (2H, m, ArH), 7.19 (1H, t, J = 10, ArH), 7.09 (3H, m,
ArH), 6.45 (2H, m, ArH), 4.44 (3H, m, NCH(R)CH2O), 2.33 (1H, m,
CHMe2), 0.99 (3H, d, J = 10, CH(CH3)2), 0.91 (3H, d, J =10, J =
CH(CH3)2), −0.86 (3H, s, AlMe), −0.89 (3H, s, AlMe). 13C NMR
(CDCl3, 298 K): δ 169.87 (CN), 157.07, 147.12, 135.32, 130.74,
129.94, 128.33, 124.81, 117.21, 113.75, 105.04, 67.90 (NCH(R)
CH2O), 67.57 (NCH(R)CH2O), 29.94 (CHMe2), 19.51 (CHMe2),
14.33 (CHMe2), −7.77 (AlCH3), −9.93 (AlCH3).
(L1b)AlMe2 (2b).28 Yield: 252 mg (0.690 mmol), 69%. [α]D
=
+96.7° (c 0.667, toluene). 1H NMR (CDCl3, 298 K): δ 7.70 (1H, d, J
= 10, ArH), 7.12 (2H, m, ArH), 7.08 (2H, m, ArH), 6.45 (1H, t, J = 5,
ArH), 6.05 (1H, d, J = 5, ArH), 4.48 (3H, m, NCH(R)CH2O), 2.35
(1H, m, CHMe2), 2.12 (3H, s, ArMe), 2.10 (3H, s, ArMe), 0.99 (3H,
d, J = 10, CH(CH3)2), 0.90 (3H, d, J = 10, CH(CH3)2), −0.88 (3H, s,
AlMe), −0.93 (3H, s, AlMe). 13C NMR (CDCl3, 298 K): δ 169.99,
(CN), 156.16, 143.21, 137.05, 136.82, 135.77, 130.98, 128.92,
128.87, 125.41, 116.19, 113.63, 104.50, 67.75 (NCH(R)CH2O), 67.54
(NCH(R)CH2O), 29.89 (CHMe2), 19.44 (CHMe2), 18.69 (ArCH3),
18.64 (ArCH3), 14.27 (CHMe2), −8.25 (AlCH3), −8.96 (AlCH3).
(L1c)AlMe2 (2c). Yield: 200 mg (0.539 mmol), 53%. [α]D = −422°
(4R)-4,5-Dihydro-2-(2′-anilinophenyl)-4-isobutyloxazole (HL1e).
Yield: 254 mg (0.861 mmol), 86%. 1H NMR (CDCl3, 298 K): δ
10.48 (1H, s, NH), 7.73 (1H, d, ArH), 7.26 (4H, m, ArH), 7.18 (2H, t,
ArH), 6.97 (1H, t, ArH), 6.67 (1H, t, ArH), 4.35 (2H, m,
NCH(R)CH2O), 3.82 (1H, t, NCH(R)CH2O), 1.80 (1H, m
CH2CH), 1.59 (1H, m, CH2CH), 1.36 (1H, m, CH2CH), 0.93 (6H,
m, CHCH3). 13C NMR (CDCl3, 298 K): δ 163.45, 145.54, 141.49,
131.86, 129.90, 129.27, 122.66, 121.56, 116.93, 113.11, 110.44, 71.48
(NCH(R)CH2O), 65.17 (NCH(R)CH2O), 45.65 (CH2CHMe2),
25.84 (CH2CHMe2), 22.98 (CH2CHMe2), 22.64 (CH2CHMe2).
GC/MS: m/z 294 [M]+ (100), 263, 237, 194, 167, 139. HRMS
(EI+): m/z calcd for C19H23N2O [M + H]+ 295.18104; found
295.18182.
1
(c 3.86, toluene). H NMR (CDCl3, 298 K): δ 7.77 (1H, d, J = 10,
ArH), 7.5−7.3 (7H, m, ArH), 7.15 (2H, m, ArH); 7.05 (2H, m, ArH),
6.50 (1H, t, J = 10, ArH), 6.43 (1H, d, J = 10, ArH), 5.36 (1H, m,
NCH(R)CH2O), 4.96 (1H, m, NCH(R)CH2O), 4.57 (1H, m,
NCH(R)CH2O), −0.94 (3H, s, AlMe), −1.55 (3H, s, AlMe). 13C
NMR (CDCl3, 298 K): δ 170.18 (CN), 157.33, 146.94, 138.47,
135.68, 130.88, 129.95, 129.43, 129.35, 128.24 128.05, 124.86, 117.32,
113.84, 104.59, 75.28 (NCH(R)CH2O), 66.98 (NCH(R)CH2O),
−9.00 (MeAl), −9.79 (MeAl). Anal. Calcd for C23H23N2OAl: C, 74.58;
H, 6.26; N, 7.56. Found: C, 74.20; H 6.33; N, 7.55.
(4S)-4,5-Dihydro-2-(2′-(3,5-bis(trifluoromethyl)anilino)phenyl)-4-
1
isopropyloxazole (HL1g). Yield: 670 mg (1.61 mmol), 87%. H NMR
(CDCl3, 298 K): δ 11.00 (1H, s, NH), 7.74 (1H, d, ArH), 7.50 (2H, s,
ArH), 7.30−7.27 (3H, m, ArH), 6.80 (1H, t, ArH), 4.28 (1H, m,
NCH(R)CH2O), 4.04 (1H, m, NCH(R)CH2O), 3.95 (1H, m,
NCH(R)CH2O), 1.70 (1H, m,CHCH3), 0.93 (3H, d, CHCH3),
0.84 (3H, d, CHCH3). 13C NMR (CDCl3, 298 K): δ 163.66, 143.79,
143.49, 133.01, 132.74, 132.40, 130.50, 124.66, 122.48, 119.65, 118.89,
114.82, 114.30, 112.59, 72.99 (NCH(R)CH2O), 69.47 (NCH(R)
CH2O), 33.47 (CHMe2), 19.14 (CHMe2), 18.88 (CHMe2). GC/MS:
m/z 416 [M]+, 373 (100), 345, 316, 291, 234, 182. HRMS (EI+): m/z
calcd for C20H19N2OF6 [M + H]+ 417.14016; found 417.14115.
(4S)-4,5-Dihydro-2-(2′-(4-methoxyanilino)phenyl)-4-isopropylox-
azole (HL1h). Yield: 558 mg (1.79 mmol), 84%. 1H NMR (CDCl3, 298
K): δ 10.36 (1H, s, NH), 7.80 (1H, d, ArH), 7.22 (3H, d, ArH), 7.11
(1H, d, ArH); 6.93 (2H, d, ArH), 6.70 (1H, t, ArH), 4.38 (1H, t,
NCH(R)CH2O), 4.15 (1H, m, NCH(R)CH2O), 4.06 (1H, t,
NCH(R)CH2O), 3.83 (3H, s, ArOMe), 1.82 (1H, m, CHCH3), 1.06
(3H, d, CHCH3), 0.96 (3H, d, CHCH3). 13C NMR (CDCl3, 298 K): δ
163.36 (CN), 156.28, 147.33, 134.47, 132.13, 130.03, 125.10,
116.19, 114.76, 112.46, 109.58, 73.08 (NCH(R)CH2O), 69.10
(NCH(R)CH2O), 55.75 (ArOMe), 33.50 (CHMe2), 19.26
(CHMe2), 18.97 (CHMe2). GC/MS: m/z 310 [M]+ (100), 267,
237, 209, 182, 154. HRMS (EI+): m/z calcd for C19H23N2O2 [M +
H]+ 311.17595; found 311.17612.
(L1d)AlMe2 (2d). Yield: 98.4 mg (0.247 mmol), 50%. [α]D = −162°
1
(c 2.62, toluene). H NMR (CDCl3, 298 K): δ 7.80 (1H, d, J = 10,
ArH), 7.40 (3H, m, ArH), 7.35 (2H, m, ArH), 7.09 (3H, m, ArH), 7.04
(1H, m, ArH), 6.49 (1H, t, J = 10, ArH), 6.06 (1H, d, J = 10, ArH),
5.37 (1H, m, NCH(R)CH2O), 5.01 (1H, m, NCH(R)CH2O), 4.58
(1H, m, NCH(R)CH2O), 2.11 (3H, s, ArMe), 2.04 (3H, s, ArMe),
−0.92 (3H, s, AlMe), −1.62 (3H, s, AlMe). 13C NMR (CDCl3, 298 K):
δ 170.30 (CN), 156.42, 143.05, 138.86, 136.97, 136.68, 136.00,
131.06, 129.34, 128.83, 127.91, 125.38, 116.26, 113.68, 104.11, 75.38
(NCH(R)CH2O), 66.94 (NCH(R)CH2O), 18.58 (MePh), −9.08
(MeAl), −9.46 (MeAl). Anal. Calcd for C25H27N2OAl: C, 75.35; H,
6.83; N, 7.03. Found: C, 77.33; H, 7.18; N, 7.08.
(L1e)AlMe2 (2e). Yield: 245 mg (0.698 mmol), 67%. [α]D = −388°
1
(c 1.73, toluene). H NMR (CDCl3, 298 K):): δ 7.68 (1H, d, J = 10,
ArH), 7.38 (2H, m, ArH), 7.19 (1H, m, ArH), 7.11 (3H, m, ArH), 6.45
(2H, m, ArH), 4.72 (1H, m, NCH(R)CH2O), 4.41 (1H, m,
NCH(R)CH2O), 4.23 (1H, m, NCH(R)CH2O), 1.95 (1H, m,
CHCH3), 1.62 (2H, m, CH2CH), 0.99 (6H, m, CH(CH3)2), −0.85
(3H, s, AlMe), −0.90 (3H, s, AlMe). 13C NMR (CDCl3, 298 K): δ
(4S)-4,5-Dihydro-2-(2′-(2-phenoxyanilino)phenyl)-4-isopropylox-
azole (HL1i). Yield: 659 mg (1.77 mmol), 88%. 1H NMR (CDCl3, 298
E
dx.doi.org/10.1021/om401226j | Organometallics XXXX, XXX, XXX−XXX